Largest biotech companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Amgen leads the 24 biotech companies ranked by cash on hand, at THB 310B, ahead of BioNTech (THB 289.2B) and Gilead Sciences (THB 256.9B). Figures as of 18 Nov 2026, 20:14 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenTHB 310B
- Median
- THB 14.7B
- Combined market value
- THB 28.43T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | THB 310B | THB 8.15T | THB 15,065.34 | 3.12% down | 34% up | ||
| 2 | BioNTechBNTX · Health Care | THB 289.2B | THB 704B | THB 2,839.40 | 1.47% down | 16% down | ||
| 3 | Gilead SciencesGILD · Health Care | THB 256.9B | THB 7.12T | THB 5,739.41 | 0.74% down | 33% up | ||
| 4 | argenxARGX · Health Care | THB 118.6B | THB 2.02T | THB 32,073.69 | 0.32% down | 4% up | ||
| 5 | BiogenBIIB · Health Care | THB 102.2B | THB 1.25T | THB 8,487.62 | 0.34% down | 49% up | ||
| 6 | ModernaMRNA · Health Care | THB 88.1B | THB 2.73T | THB 6,735.63 | 4.09% down | 755% up | ||
| 7 | ImmunovantIMVT · Health Care | THB 30.6B | THB 234.5B | THB 1,132.91 | 0.45% up | 43% up | ||
| 8 | QiagenQGEN · Health Care | THB 28.5B | THB 347.9B | THB 1,684.59 | 0.29% down | 12% up | ||
| 9 | Neurocrine BiosciencesNBIX · Health Care | THB 24.2B | THB 560.1B | THB 5,533.78 | 1.79% down | 20% up | ||
| 10 | RepligenRGEN · Health Care | THB 19.2B | THB 375B | THB 5,865.91 | 6.51% up | 5% up | ||
| 11 | Krystal BiotechKRYS · Health Care | THB 16.9B | THB 316B | THB 10,662.76 | 5.17% up | 46% up | ||
| 12 | ExelixisEXEL · Health Care | THB 16.4B | THB 567.9B | THB 2,327.28 | 0.04% up | 63% up | ||
| 13 | Revolution MedicinesRVMD · Health Care | THB 13B | THB 1.17T | THB 5,426.30 | 1.79% down | 131% up | ||
| 14 | Kymera TherapeuticsKYMR · Health Care | THB 12.1B | THB 351.6B | THB 4,117.99 | 0.21% down | 87% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | THB 11.8B | THB 133.6B | THB 1,377.08 | 1.00% up | 21% down | ||
| 16 | Scholar Rock HoldingSRRK · Health Care | THB 11B | THB 199B | THB 1,631.10 | 6.54% up | 14% up | ||
| 17 | Bio-TechneTECH · Health Care | THB 9B | THB 388.3B | THB 2,471.78 | 0.21% up | 26% up | ||
| 18 | Kodiak SciencesKOD · Health Care | THB 7.1B | THB 216.3B | THB 3,307.45 | 0.61% up | 396% up | ||
| 19 | Twist BioscienceTWST · Health Care | THB 6.2B | THB 270B | THB 3,959.74 | 4.11% up | 340% up | ||
| 20 | VaxcytePCVX · Health Care | THB 5.9B | THB 314.5B | THB 1,987.00 | 1.50% down | 22% up | ||
| 21 | Halozyme TherapeuticsHALO · Health Care | THB 4.5B | THB 372.2B | THB 3,264.91 | 0.18% up | 37% up | ||
| 22 | ImmunityBioIBRX · Health Care | THB 3B | THB 241.2B | THB 226.76 | 6.67% up | 193% up | ||
| 23 | Adaptive BiotechnologiesADPT · Health Care | THB 2.4B | THB 157.2B | THB 971.26 | 0.39% up | 88% up | ||
| 24 | CG OncologyCGON · Health Care | THB 1.1B | THB 243B | THB 2,720.20 | 1.47% up | 85% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 33.9600 THB).
Questions and answers
Which biotech companies rank first by cash on hand?
Amgen (THB 310B), BioNTech (THB 289.2B) and Gilead Sciences (THB 256.9B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 20:14 UTC.
How many biotech companies are in this ranking?
24 are ranked by cash on hand.
What are these biotech companies worth together?
The 24 biotech companies ranked by cash on hand have a combined market value of THB 28.43T as of 18 Nov 2026, 20:14 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.